CLASS II ONGOING Drug recall · Reported 29 Jan 2025 · FDA Enforcement Report

Ultra Repair Cream, colloidal oatmeal 0.5%, Coconut Vanilla recalled

First Aid Beauty is recalling Ultra Repair Cream, colloidal oatmeal 0.5%, Coconut Vanilla, distributed nationwide in the US. The recall was initiated on 23 Dec 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots 24D44, Exp 4/10/2026 & 24D45, 4/11/2026
Quantity recalled2756 jars

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0206-2025
FDA event ID
96052
Recalling firm
First Aid Beauty, Newton, MA
Classification
Class II
Status
Ongoing
Recall initiated
23 Dec 2024
FDA classified
21 Jan 2025
Reported
29 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail

Timeline

23 Dec 2024Recall initiated by company
21 Jan 2025Classified by FDA+29 days
29 Jan 2025Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations; product intended for quarantine was inadvertently distributed

Product as listed by the FDA

First Aid Beauty Ultra Repair Cream, colloidal oatmeal 0.5%, Coconut Vanilla, Net Wt. 396.8 g (14 OZ), DISTR. BY: First Aid Beauty LTD, Newton, MA, 02458, UPC 8 15517 02955 6

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

CGMP Deviations; product intended for quarantine was inadvertently distributed

Which lots are affected?

Lots 24D44, Exp 4/10/2026 & 24D45, 4/11/2026

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.